APPLICATION OF IMODS IN IMMUNO-ONCOLOGY
Our pipeline comprises Biclonics® for solid and hematological tumors that target combinations of growth factor receptors and immunomodulatory molecules. See what's in our pipeline
We make our technologies available in partnerships based on promising target combinations. Please contact us for further information.